Upcoming Events
Past Events
Christiane Angermann (Germany) | Ricardo Carvalho (Portugal)
The heart failure patient through a holistic lens (Full)
Christiane Angermann (Germany) | Ricardo Carvalho (Portugal)
The heart failure patient through a holistic lens (Summary)
Subodh Verma (Canada) | Soo Yong Lee (Korea)
SGLT2 inhibitor: Essential foundation for heart failure treatment (Summary 1)
Subodh Verma (Canada) | Soo Yong Lee (Korea)
SGLT2 inhibitor: Essential foundation for heart failure treatment (Summary 2)
Subodh Verma (Canada) | Soo Yong Lee (Korea)
SGLT2 inhibitor: Essential foundation for heart failure treatment (Full; Day 1)
Subodh Verma (Canada) | Soo Yong Lee (Korea)
SGLT2 inhibitor: Essential foundation for heart failure treatment (Full; Day 2)
Andrew Coats (Australia)
Heart failure treatment from then to now (Summary 2)
Andrew Coats (Australia)
Heart failure treatment from then to now (Full; Day 1)
Andrew Coats (Australia) | Michael Bohm (Germany)
Heart failure treatment from then to now (Full; Day 2)
Adrian Liew (Singapore) | Per Henrik Groop (Finland) | Michel Jadoul (Belgium)
Evolving evidence in the role of empagliflozin in kidney diseases
Andrew Coats (Australia) | Anita Sharma (Australia) | Carol Pollock (Australia) | Roger Chen (Australia)
Demystifying complex diabetic kidney disease – A multidisciplinary case-based approach to management
Oscar Naidas (Philippines) | Michel Jadoul (Belgium)
